edaravone has been researched along with Alveolitis, Fibrosing in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, we aimed to investigate the effects of diterpene ginkgolides meglumine injection (DGMI) on paraquat (PQ)-induced lung injury and pulmonary fibrosis in rats." | 7.88 | Diterpene ginkgolides meglumine injection protects against paraquat-induced lung injury and pulmonary fibrosis in rats. ( Li, GP; Li, L; Liu, Q; Wang, ZZ; Xiao, W; Xu, ZL; Yang, H; Zhou, J; Zong, SB, 2018) |
| " In this study, we evaluated whether edaravone could protect against lung injury and pulmonary fibrosis in paraquat-treated rats." | 7.77 | Edaravone, a novel antidote against lung injury and pulmonary fibrosis induced by paraquat? ( Qian, X; Sun, H; Yang, L; Zhi, Q, 2011) |
| " The aim of this study was to examine the effect of edaravone, a free radical scavenger, on the development of fibrosis and autoimmunity in two different mouse models of SSc." | 7.77 | The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis. ( Asano, Y; Iwata, Y; Kadono, T; Ogawa, A; Ogawa, F; Sato, S; Shimizu, K; Takenaka, M; Yanaba, K; Yoshizaki, A, 2011) |
| "Pulmonary fibrosis is responsible for the both short-term and long-term outcomes in patients with acute respiratory distress syndrome (ARDS)." | 5.48 | Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling. ( Chen, G; Lai, R; Liang, Z; Su, X; Wang, X, 2018) |
| "To observe whether edaravone can protect organs and inhibit pulmonary fibrosis in patients with paraquat poisoning and to provide a method for clinical intervention for paraquat poisoning." | 3.91 | Retrospective study of clinical features and prognosis of edaravone in the treatment of paraquat poisoning. ( Shinan, N; Wei, Z; Xin, C; Yi, R; Zhaorui, S; Zhizhou, Y, 2019) |
| "In this study, we aimed to investigate the effects of diterpene ginkgolides meglumine injection (DGMI) on paraquat (PQ)-induced lung injury and pulmonary fibrosis in rats." | 3.88 | Diterpene ginkgolides meglumine injection protects against paraquat-induced lung injury and pulmonary fibrosis in rats. ( Li, GP; Li, L; Liu, Q; Wang, ZZ; Xiao, W; Xu, ZL; Yang, H; Zhou, J; Zong, SB, 2018) |
| " In this study, we evaluated whether edaravone could protect against lung injury and pulmonary fibrosis in paraquat-treated rats." | 3.77 | Edaravone, a novel antidote against lung injury and pulmonary fibrosis induced by paraquat? ( Qian, X; Sun, H; Yang, L; Zhi, Q, 2011) |
| " The aim of this study was to examine the effect of edaravone, a free radical scavenger, on the development of fibrosis and autoimmunity in two different mouse models of SSc." | 3.77 | The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis. ( Asano, Y; Iwata, Y; Kadono, T; Ogawa, A; Ogawa, F; Sato, S; Shimizu, K; Takenaka, M; Yanaba, K; Yoshizaki, A, 2011) |
| "Pulmonary fibrosis is responsible for the both short-term and long-term outcomes in patients with acute respiratory distress syndrome (ARDS)." | 1.48 | Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling. ( Chen, G; Lai, R; Liang, Z; Su, X; Wang, X, 2018) |
| "Lung injury was induced in female ICR mice by intratracheal instillation of 5 mg x kg(-1) of BLM." | 1.35 | Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice. ( Bando, M; Gejyo, F; Hosono, T; Ishii, Y; Ohno, S; Sugiyama, Y; Suzuki, E; Tajima, S; Takada, T; Yamasawa, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Lai, R | 1 |
| Su, X | 1 |
| Chen, G | 1 |
| Liang, Z | 1 |
| Li, GP | 1 |
| Yang, H | 1 |
| Zong, SB | 1 |
| Liu, Q | 1 |
| Li, L | 1 |
| Xu, ZL | 1 |
| Zhou, J | 1 |
| Wang, ZZ | 1 |
| Xiao, W | 1 |
| Yi, R | 1 |
| Zhizhou, Y | 1 |
| Zhaorui, S | 1 |
| Wei, Z | 1 |
| Xin, C | 1 |
| Shinan, N | 1 |
| Tajima, S | 1 |
| Bando, M | 1 |
| Ishii, Y | 1 |
| Hosono, T | 1 |
| Yamasawa, H | 1 |
| Ohno, S | 1 |
| Takada, T | 1 |
| Suzuki, E | 1 |
| Gejyo, F | 1 |
| Sugiyama, Y | 1 |
| Fujita, M | 1 |
| Mizuta, Y | 1 |
| Ikegame, S | 1 |
| Ouchi, H | 1 |
| Ye, Q | 1 |
| Harada, E | 1 |
| Inoshima, I | 1 |
| Yoshimi, M | 1 |
| Watanabe, K | 1 |
| Nakanishi, Y | 1 |
| Zhi, Q | 1 |
| Sun, H | 1 |
| Qian, X | 1 |
| Yang, L | 1 |
| Yoshizaki, A | 1 |
| Yanaba, K | 1 |
| Ogawa, A | 1 |
| Iwata, Y | 1 |
| Ogawa, F | 1 |
| Takenaka, M | 1 |
| Shimizu, K | 1 |
| Asano, Y | 1 |
| Kadono, T | 1 |
| Sato, S | 1 |
7 other studies available for edaravone and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling.
Topics: Animals; Antipyrine; Dose-Response Relationship, Drug; Edaravone; Free Radical Scavengers; Lipopolys | 2018 |
Diterpene ginkgolides meglumine injection protects against paraquat-induced lung injury and pulmonary fibrosis in rats.
Topics: Acute Lung Injury; Animals; Antipyrine; Dose-Response Relationship, Drug; Edaravone; Ginkgolides; In | 2018 |
Retrospective study of clinical features and prognosis of edaravone in the treatment of paraquat poisoning.
Topics: Adult; Biomarkers; Cytokines; Edaravone; Female; Humans; Male; Oxidative Stress; Paraquat; Prognosis | 2019 |
Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice.
Topics: Animals; Antipyrine; Bleomycin; Bronchoalveolar Lavage Fluid; Dinoprostone; Edaravone; Female; Free | 2008 |
Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antipyrine; Apoptosis; Bleomycin; Bronchi; Bronchoalveolar Lav | 2008 |
Edaravone, a novel antidote against lung injury and pulmonary fibrosis induced by paraquat?
Topics: Animals; Antidotes; Antipyrine; Bronchoalveolar Lavage Fluid; Edaravone; Herbicides; Hydroxyproline; | 2011 |
The specific free radical scavenger edaravone suppresses fibrosis in the bleomycin-induced and tight skin mouse models of systemic sclerosis.
Topics: Animals; Antipyrine; Bleomycin; Disease Models, Animal; Edaravone; Fibrosis; Free Radical Scavengers | 2011 |